Search results
NanoViricides completes Phase 1 trial for respiratory viral infection candidate
Proactive Investors· 1 week agoIt has been found to be active against coronavirus infection, RSV infection, and smallpox and...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 1 week agoI Clinical Trial of NV-387 is completed successfully and data lock is expected soon. The Phase 1...